Supernus Pharmaceuticals (SUPN)
Develops CNS medicines spanning ADHD, Parkinson’s disease, postpartum depression, and epilepsy.
$43.65
vs last close+0.87 (+2.03%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 104.93% | 60.99M shares | |
|---|---|---|---|
| 340 holders · as of Jun 30, 2026 | |||
| Insiders | 6.48% | 3.77M shares | |
| 9 holders · as of Aug 14, 2026 | |||
| Adds to | 111.41% | ||
58.13M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 111.41%; nothing is left for Other.
13F, as of Jun 30, 2026
340 holders · 60.99M shares · 47 new positions · 168 increased · 113 reduced · 40 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 9.35M | 16.09% | +552.8K | Aug 7, 2026 |
| Millennium Management LLC | 3.85M | 6.63% | +537.2K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 3.31M | 5.69% | +66.7K | Aug 13, 2026 |
| Armistice Capital, LLC | 2.65M | 4.55% | +750.9K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.52M | 4.33% | +49.5K | Aug 13, 2026 |
| State Street Corp | 2.46M | 4.23% | +171.7K | Aug 7, 2026 |
| Macquarie Management Holdings, Inc. | 2.38M | 4.09% | +341.1K | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 2.08M | 3.58% | −228.9K | Aug 11, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.70% | 8.20M | 13G | Apr 22, 2025 |
| Armistice Capital, LLC | 8.58% | 4.81M | 13G | Aug 15, 2025 |
| Vanguard Portfolio Management | 5.66% | 3.26M | 13G | Apr 29, 2026 |
| Millennium Management LLC | 5.30% | 3.04M | 13G | Feb 2, 2026 |
| Vanguard Capital Management | 5.03% | 2.90M | 13G | Apr 30, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 17, 2026 | Padmanabh P. Bhattofficer: Sr. VP of IP, CSO | Sale · 2 lots | 50,000 | $50.30 | 17,044 |
| Mar 18, 2026 | Padmanabh P. Bhattofficer: Sr. VP of IP, CSO | Sale · 2 lots | 7,250 | $49.60 | 17,044 |
| Mar 16, 2026 | Padmanabh P. Bhattofficer: Sr. VP of IP, CSO | Sale · 2 lots | 50,000 | $50.28 | 17,044 |
| Mar 12, 2026 | Frederick M. Hudsondirector | Sale | 5,369 | $50.61 | 60,413 |
| Mar 13, 2026 | Jack A. Khattardirector, officer: President, CEO | Sale · 3 lots | 35,000 | $50.37 | 958,100 |
| Mar 10, 2026 | William Todd Horichofficer: SVP, Commercial Operations | Sale | 4,439 | $55.00 | 0 |
| Mar 9, 2026 | William Todd Horichofficer: SVP, Commercial Operations | Sale | 4,438 | $54.00 | 4,439 |
| Mar 9, 2026 | Frank Mottolaofficer: SVP, Chief Tech. Ops. Officer | Sale | 1,623 | $53.65 | 18,440 |
| Mar 6, 2026 | Georges Gemayeldirector | Sale | 8,787 | $53.00 | 27,277 |
| Mar 5, 2026 | Georges Gemayeldirector | Sale | 10,000 | $53.71 | 28,159 |
House and Senate disclosures
Not reported.